Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects

NCT02071381 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DW330SR 45mg
DRUG: DW1030 75mg

Sponsor

Daewon Pharmaceutical Co., Ltd.